Interrogate the SARS-CoV-2 genome with NGS

Form submitted successfully. Thank you. You may access the webinars below.


SARS-CoV-2: Insights from sequencing the complete viral genome

WF23567-speaker-timothy-triche

Timothy Triche, MD, PhD
Co-Director, Center for Personalized Medicine Program, Children's Hospital Los Angeles


SARS-CoV-2 genome sequencing from post-mortem FFPE lung tissue

WF23567-speaker-nicky-dhaene

Nicky D’Haene, MD PhD
Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium


Integrated approach of virus sequencing and host genetics in a COVID-19 North Portuguese cohort

WF23567-speaker-luisa-pereira

Dr. Luisa Pereira
Principal Researcher & Group Leader, i3S-IPATIMUP


Evolutionary trajectories of SARS-CoV-2 and laboratories challenges

WF23567-speaker-barbara-bartolini

Dr. Barbara Bartolini
Senior Scientist at Microbiology Laboratory and Infectious Diseases Biorepository at the National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome, Italy


A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece

WF23567-speaker-ioannis-karakasiliotis

Dr. Ioannis Karakasiliotis
Assistant Professor in Medical Biology and Molecular Virology Medical School, Democritus University of Thrace, Alexandroupolis, Greece


The role of the wastewater-based epidemiology at the time of the COVID-19 pandemic

WF23567-speaker-ing-shelesh-agrawal

Dr. Ing. Shelesh Agrawal
Microbiology Group Leader, Technical University of Darmstadt, Institut IWAR, Germany


Beyond emergency testing: staying ahead of SARS-CoV-2 with next-generation sequencing

WF23567-speaker-amy-carroll

Amy Carroll, PhD
Director of Medical Affairs, Thermo Fisher Scientific


Epidemiology: beyond detection to control the virus

WF23567-speaker-jose-luis-costa

Dr. José Luís Costa
Director Medical Affairs EMEA, Clinical NGS and Oncology Division, Thermo Fisher Scientific

Featured Ion Torrent NGS solutions for SARS-CoV-2 research

Rapid sequencing of the complete SARS-CoV-2 genome for epidemiology research

The Ion AmpliSeq SARS-CoV-2 Research Panel for the Genexus Integrated Sequencer enables complete viral genome sequencing and variant detection of SARS-CoV-2 with >99% coverage. Rapidly go from nucleic acid to variant report in under a single day with minimal hands-on time. Bring simple, practical NGS to your lab. Learn more

Request virtual demo of the Ion Torrent Genexus System

Comprehensive, end-to-end immunology solutions for vaccine research

Ion Torrent targeted NGS provides a multi-dimensional approach to repertoire sequencing and immune response, enabling a deeper understanding of the adaptive immune system and its role in human health and response to infection and vaccines. Each assay is part of an end-to-end workflow that includes simple data analysis tools so you can focus on the biological meaning of your data.

Discover our solutions for vaccine research and study additional factors that influence host genetics and immune pathways:

  • TCR and BCR sequencing
  • Microbiome analysis
  • Gene expression and transcriptome analysis